| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting point | 161.0 to 165.0 °C |
Active Pharmaceutical Ingredients
Ravuconazole
4-[2-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile
| Purity / Analysis Method | >98.0%(HPLC)(qNMR) |
| Molecular Formula / Molecular Weight | C22H17F2N5OS = 437.47 |
| Storage Temperature | Frozen (-20°C) |
| CAS RN | 182760-06-1 |
| Unit | Price |
| 250 mg | 8250 |
| 1 g | 23350 |
| 5 g | 69950 |
| Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|




